Corbevax

…

The Indian government has likely approved Biological E's Corbevax as a precaution dose for those above 18 years of age who are fully vaccinated with either Covishield or Covaxin, official sources told news agency PTI. This is for the first…

…

NEW DELHI : Hyderabad-based pharma company Biological E. Limited (BE) on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India (DCGI) as a heterologous Covid-19…

Vaccine maker Biological E (BE) on Monday said it has reduced the price of its Covid-19 vaccine Corbevax from Rs 840 to Rs.250 a dose inclusive of GST, for the private market. With the price cut, the vaccine will be available for the end…

Developed by the Hyderabad-based Biological E Ltd in India, this two-dose vaccine shows a 90 per cent effectiveness against the original Wuhan strain and more than 80 per cent against the Delta variant…

New Delhi: The Union Ministry of Health & Family Welfare on Tuesday asked States and Union Territories to ensure that vaccine is administered to only those who have completed the age of 12 years and not to ones who have…

<!-- -->Coronavirus vaccine: The CORBEVAX vaccine is patent-free. (Representational)Washington: Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with…

The country's drug regulator has given emergency approval to the Biological E's COVID-19 vaccine Corbevax for 12-18 years. It is the second vaccine for children after Bharat Biotech's Covaxin. However, the government has not yet…

Another vaccine in India has been recommended for Emergency Use Authorization (EUA) from the Subject Expert Committee, according to a news report by the ANI agency. Hyderabad-based pharmaceutical company Biological E's Covid…